Results 221 to 230 of about 99,136 (277)

Oral Squamous Cell Carcinoma in a Patient with Myelodysplastic Syndrome: Report of a Case and Literature Review. [PDF]

Front Dent
Omidsalar P, Moradzadeh Khiavi M, Sheykhbahaei N.   +2 more
europepmc   +1 more source

Necrotising Fasciitis in Patients With Diabetes: A Systematic Review of Mortality‐Associated Clinical Factors

International Wound Journal, Volume 23, Issue 2, February 2026.
ABSTRACT Necrotising fasciitis (NF) is a rapidly progressing, life‐threatening infection with mortality rates that are exceedingly high. Despite the notably high risks of developing NF in patients with diabetes mellitus (DM), factors associated with mortality in this population are poorly understood.
Ashmit Daiyan Mustafa, Karan Varshney, Tanish Rao, Pavan Shet, Lavina Rao, Prerana Ghosh, Yat Cheung Chung   +6 more
wiley   +1 more source

Triptolide combined with arsenic trioxide induces apoptosis of myelodysplastic syndrome cells by inhibiting the NF-κB signaling pathway. [PDF]

Medicine (Baltimore)
Sheng L, Zhu Y, Wen Z, Fang M, Gu S, Ye L, Hua H.   +6 more
europepmc   +1 more source

Leukemic Regression After G‐CSF Withdrawal in Severe Congenital Neutropenia

eJHaem, Volume 7, Issue 1, February 2026.
Agnese Roveta, Irene Trambusti, Marco Tellini, Laura Giunti, Francesca Fioredda, Veronica Tintori, Annalisa Tondo, Francesco Pegoraro, Marinella Veltroni   +8 more
wiley   +1 more source

Cost‐effectiveness of a hypothetical assay to evaluate stored blood quality prior to transfusion

Vox Sanguinis, Volume 121, Issue 2, Page 142-151, February 2026.
Abstract Background and Objectives Unsuccessful red blood cell (RBC) transfusion, necessitating unscheduled repeat transfusion, is common and costly. Several technologies have been developed to assess stored blood quality, but the potential cost‐effectiveness of pretransfusion testing versus no testing to prevent unscheduled re‐transfusion is unknown ...
Melissa C. Caughey, Tara Templin, Nareg H. Roubinian, Matthew S. Karafin   +3 more
wiley   +1 more source

Frontline treatment of IDH1-mutated myelodysplastic syndrome with ivosidenib: clinical cases and therapeutic insights. [PDF]

Ther Adv Hematol
Antonios B, Dutton N, Fazal S.
europepmc   +1 more source

Therapeutic targeting of chromatin alterations in leukemia and solid tumors

International Journal of Cancer, Volume 158, Issue 2, Page 382-408, 15 January 2026.
Abstract Alterations in chromatin conformation and post‐translational modification of histones have become increasingly recognized as critical drivers of cancer development, progression, and therapy resistance. Recent advances in drug development have led to the establishment of several highly selective small molecule inhibitors, several of which are ...
Florian Perner, Tobias Berg, Daniel Sasca, Sophie‐Luise Mersiowsky, Jayant Y. Gadrey, Johanna Thomas, Michael W. M. Kühn, Michael Lübbert   +7 more
wiley   +1 more source

Remimazolam-Based Anesthetic Management in a Patient with Severe Aortic Stenosis and Myelodysplastic Syndrome-Related Thrombocytopenia: A Case Report. [PDF]

J Clin Med
Lee SH, Cho SB, Choo H, Park J, Byun SH.
europepmc   +1 more source

DNA methyltransferase inhibitors in hematological malignancies and solid tumors

International Journal of Cancer, Volume 158, Issue 2, Page 433-461, 15 January 2026.
Abstract Epigenetic modifications such as DNA methylation play a fundamental role in oncogenesis and the progression of neoplasms neoplasias. DNA methyltransferase inhibitors (DNMTi) constitute a family of therapeutic agents that impede the methylation at the 5‐position on cytosine nucleotides, thereby modulating the epigenetic regulation of tumor ...
Valentin Wenger, Guillermo Garcia‐Manero, Robert Zeiser, Michael Lübbert   +3 more
wiley   +1 more source

A Hematologic Twist: Zinc-Induced Copper Deficiency Mimicking Myelodysplastic Syndrome. [PDF]

Cureus
Mims MH, Reid ES, Hash MG, Maddux A.
europepmc   +1 more source